Quantcast
Last updated on April 18, 2014 at 9:14 EDT

Latest German inventions Stories

2012-04-23 23:00:49

Former NBA Star Chris Herren´s message of hope and perserverence in a triumphant battle with the scourge of drug addiction has captured the imagination of young people across the country. Once one of the most highly touted Division 1 basketball prospects ever to emerge from the Northeast, Herren lost it all to cocaine, oxycodone, and heroin addictions, then clawed his way back from the brink of death to fashion a new life as an exemplar of courage and generosity. Now Chris Herren will...

2012-04-23 21:20:09

Patients with advanced chronic obstructive pulmonary disease (COPD) and shortness of breath found that opioids provided relief and improved their quality of life, states an article in CMAJ (Canadian Medical Association Journal). However, physicians are reluctant to prescribe opioids for this condition, meaning many people will not benefit from this treatment. The prevalence of COPD in Canada is increasing, and shortness of breath (dyspnea) is a major symptom that is difficult to treat and...

2012-04-12 06:26:00

LANSING, Mich., April 12, 2012 /PRNewswire/ -- Accident Fund Holdings, Inc. (AFHI) recently created a comprehensive narcotics program to help reduce the health risks of these drugs on injured workers and ultimately provide a mechanism for them to get back to work sooner. (Logo: http://photos.prnewswire.com/prnh/20100727/DE40865LOGO ) AFHI's program incorporates data analytics, case management and peer-to-peer physician pharmaceutical review. Unique to this program is the integration of...

2012-04-10 14:22:32

BEDMINSTER, N.J. and SYDNEY, April 10, 2012 /PRNewswire/ -- QRxPharma (ASX: QRX and OTCQX: QRXPY) announced today successful completion of two Phase 1 studies in healthy volunteers for MoxDuo® CR, a controlled-release Dual-Opioid® utilising a 3:2 ratio of morphine and oxycodone. The proprietary MoxDuo CR formulation, encompassing both sustained delivery technology as well as abuse deterrent and tamper resistant features, is designed to provide at least 12 hours of analgesia in...

Florida In The Middle Of Pain-Killer Boom Once More
2012-04-10 04:45:22

The US Drug Enforcement Administration (DEA) is inspecting 6 Walgreens pharmacies and its Florida distribution center in response to a jump in purchases of oxycodone, a highly addictive pain killer. According to Reuters, the DEA has issued inspection warrants to Walgreen´s distribution center as well as stores in Hudson, Port Richey, Oviedo, Fort Meyers, and two stores in Fort Pierce, Florida. In accordance with the US Controlled Substance Act, warrants may be issued for “valid...

2012-04-06 02:20:49

BALTIMORE, April 6, 2012 /PRNewswire/ -- Ameritox(SM), the nation's leader in pain medication monitoring, commends Unlawful Narcotics Investigations, Treatment and Education, Inc. (Operation UNITE), the organizers of the inaugural National Rx Drug Abuse Summit, on its coordination of a national forum to address the prescription drug abuse epidemic. The Summit will be held April 10-12 in Orlando, Florida. "As the nation's leader in Pain Medication Monitoring...

2012-04-05 14:21:05

BEVERLY HILLS, Calif., April 5, 2012 /PRNewswire/ -- According to recent figures released by the Associated Press (AP), sales of oxycodone and hydrocodone increased dramatically between 2000 and 2010, and distribution of those painkillers has exploded in new parts of the country. Administrative director for WAISMANN METHOD® rapid detox treatment and registered addiction specialist, Clare Waismann, is cautioning Americans that this report provides evidence of a prescription painkiller...

2012-04-03 02:27:02

SHELTON, Conn., April 3, 2012 /PRNewswire/ -- Cara Therapeutics, Inc. today announced the successful completion of a first-in-man Phase I clinical trial of an oral formulation of its peptide-based, peripherally-restricted kappa opioid receptor agonist, CR845. The trial was a single-center, double-blind, placebo-controlled study to evaluate the pharmacokinetics (PK), safety and pharmacodynamics of CR845 in healthy volunteers. An intravenous formulation of CR845 is currently in clinical...

2012-04-02 02:28:38

SAN FRANCISCO, April 2, 2012 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) announced today that the first subjects were dosed last week in a Phase 1 clinical study to evaluate the pharmacokinetics and safety of NKTR-192, the company's novel short-acting mu-opioid analgesic candidate. NKTR-192 is designed to have a short-acting profile with rapid onset of pain relief for the treatment of acute pain. With a reduced rate of entry into the central nervous system (CNS) as compared to other...

2012-03-29 10:23:44

GLENVIEW, Ill., March 29, 2012 /PRNewswire-USNewswire/ -- Common practices for changing from one opioid to another, including use of published dose conversion ratios, may be contributing to the growing number of opioid-related fatalities, new research suggests. The results from a scientific literature review and a case study using this new model of opioid rotation are presented in the April issue of Pain Medicine, the official journal of the American Academy of Pain...